NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- E-Star BioTech, LLC ("E-Star” or the "Company”), an innovative developer of ...

signaling pathway including the Git2 adenylyl cyclase that produces cAMP. Additional studies showed a role for the Cgs2 phosphodiesterase that hydrolyzes cAMP to AMP. In addition, we identified ...

The nitric oxide-independent soluble guanylate cyclase activator ataciguat continued to show promise for slowing the progression of fibrocalcific aortic valve stenosis in phase I and II studies.